Why the study?
Does atenolol monotherapy reduce echocardiographic left ventricular hypertrophy in previously untreated stable hypertensive patients?
Population
20 previously untreated stable hypertensive patients with echocardiographic left ventricular hypertrophy and…
Comparison
Atenolol monotherapy for 18 months. vs Baseline measurements and healthy normotensive…
Design
Cohort
Follow-up
18 months
Authors
Loading...
Atenolol was associated with LVH regression; hypothesis-generating, requires randomized confirmation before practice change.
Does atenolol monotherapy reduce echocardiographic left ventricular hypertrophy in previously untreated stable hypertensive patients?
Atenolol monotherapy over 18 months significantly reverses echocardiographic left ventricular hypertrophy in previously untreated hypertensive patients.
Corea et al. (1983) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: